RIPGBM

RIPGBM

Biochem/physiol Actions

RIPGBM is a brain-penetrant, orally available, glioblastoma multiforme (GBM) cancer stem cells (CSCs)-selective apoptosis inducer (GBM-1/-5/-39 EC50 = 220/290/890 nM; human neural progenitor cells (NPCs)/astrocytes/lung fibroblasts EC50 = 1.7/2.8/3.5 µM) with in vivo efficacy against intracranial human GBM orthotopic xenograft tumor growth in mice (50 mg/kg bid. po.). RIPGBM undergoes a cell type-selective metabolic redox conversion to preferentially form in GBM CSCs the derivative cRIPGBM that binds receptor-interacting protein kinase 2 (RIPK2, RIP2) and promotes the formation of a proapoptotic RIPK2/caspase-1 complex.

No detailed specifications are available for this product.

There are no downloads for this product.

Code Description Colour Manufacturer Storage Temp. Solubility Form Assay Price Quantity
3576685 RIPGBM faint brown to very dark brown-red SIGMA-ALDRICH 2-8°C DMSO: 2 mg/mL, clear
£435.96 (exc VAT) per EACH
-
+
3576686 RIPGBM faint brown to very dark brown-red SIGMA-ALDRICH 2-8°C DMSO: 2 mg/mL, clear
£107.95 (exc VAT) per EACH
-
+